The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) ...
Vertex Pharmaceuticals' top line has grown significantly over the years thanks to the approval of Trikafta in 2019. The company recently obtained approval for a gene therapy treatment, Casgevy. Strong ...
You can find the Vertex Watch Company tucked among the narrow cobbled streets, quaint boutiques and flower-decked pubs of London's Shepherd Market. It fits right in. Inside its Georgian townhouse HQ, ...
Vertex Pharmaceuticals (VRTX) shares saw mild movement today, with the stock ticking slightly higher over the past week.
Wall Street expects a year-over-year decline in earnings on higher revenues when Vertex (VERX) reports results for the quarter ended March 2025. While this widely-known consensus outlook is important ...
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) will release earnings results for the second quarter, after the closing bell on Monday, Aug. 4. Analysts expect the Boston, Massachusetts-based ...